GoInVivo™ Purified anti-mouse CD279 (PD-1) A-上海雅吉生物科技有限公司

规格	价格	库存
5mg	￥ 10780	1

Product Details

Verified Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

Mouse PD-1 transfected BHK cells

Formulation

0.2 ?m filtered in phosphate-buffered solution, pH 7.2, containing no preservative. Endotoxin level is <1.0 EU/mg of the protein. (<0.01 pg/?g of the protein) as determined by the LAL test.

Preparation

The GoInVivo? antibody was purified by affinity chromatography.

Concentration

The antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL.

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C. This GoInVivo? solution contains no preservative; handle under aseptic conditions.

Application

FC - Quality tested
IHC, WB, FA - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume or 100 ?l of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

For in vivo and in vitro applications, we recommend to perform a pilot experiment to determine the optimal concentration to use for each particular experiment.

Application Notes

GoInVivo? products are guaranteed to be pathogen-free based on the IDEXX BioResearch IMPACT test via PCR. For a full listing of pathogens tested, visit the GoInVivo? Webpage.

Additional reported applications (for relevant formats of this clone) include: immunohistochemical staining of acetone-fixed frozen sections¹, Western blotting^2,6, inhibition of macrophages (but not B cells and dendritic cells) costimulated T cell proliferation^3,5, and blocking the binding of PD-1 to B7-H1 or B7-DC^3,4,8.

Application References (PubMed link indicates BioLegend citation)

Kanai, T., et al. 2003. J. Immunol. 171:4156. (FC, IHC)
Personal Communication (WB)
Yamazaki, T., et al. 2005. J. Immunol. 175:1586. (Costim)
Matsumoto, K., et al. 2004. J. Immunol. 172:2530. (Block)
Terrazas, L. I., et al. 2005. Intl. J. Parasitology. 35:1349. (Costim)
Meng, Q., et al. 2006. Invest Opthalmol Vis Sci. 47:444. (FC, WB) PubMed
Tsang JY, et al. 2011. Int Immunopharmacol. 11:604. PubMed
Takamura S, et al. 2010. J. Immunol. 184:4696. PubMed (Block)

Product Citations

Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
Lu X, et al. 2020. Sci Transl Med. 12:. PubMed
Sakamoto K, et al. 2022. Sci Rep. 12:8121. PubMed
Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
Panagioti E, et al. 2021. J Clin Invest. 131:. PubMed
Bok I, et al. 2022. JID Innov. 2:100076. PubMed

RRID

AB_2566278 (BioLegend Cat. No. 114114) AB_2566279 (BioLegend Cat. No. 114115) AB_2566280 (BioLegend Cat. No. 114116) AB_2566089 (BioLegend Cat. No. 114111) AB_2566090 (BioLegend Cat. No. 114112) AB_2566091 (BioLegend Cat. No. 114113)

Antigen Details

Structure: Ig superfamily, 50-55 kD
Distribution: Subset of double negative thymocytes, activated T and B cells
Function: Lymphocyte clonal selection, peripheral tolerance
Ligand/Receptor: PD-L1 (B7-H1), PD-L2
Cell Type: B cells, T cells, Thymocytes, Tregs
Biology Area: Apoptosis/Tumor Suppressors/Cell Death, Cancer Biomarkers, Cell Biology, Immunology, Inhibitory Molecules
Molecular Family: CD Molecules, Immune Checkpoint Receptors
Antigen References: 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook, Academic Press.
2. Agata Y, et al. 1996. Int. Immunol. 8:765.
3. Nishimura H, et al. 2001. Science 291:319.
4. Ishida Y, et al. 1992. EMBO J. 11:3887.
Gene ID: 18566 View all products for this Gene ID
UniProt: View information about CD279 on UniProt.org

上海细胞库

原代细胞

细胞培养

细胞服务

酶联试剂盒

生化试剂盒

PCR试剂盒

抗体蛋白

试剂耗材

首页 > 抗体蛋白 > 抗体

产品详情

Product Details

Antigen Details

联系我们